Ringworm in cats requires evidence-based treatment protocols that balance disease elimination with minimising the welfare costs of treatment itself.
Ringworm treatment welfare involves managing the burden of the treatment itself — repeated antifungal dips are stressful, and prolonged quarantine causes isolation welfare costs that compound with treatment duration. Evidence-based combined protocols (itraconazole plus topical antifungal) significantly reduce treatment duration compared to monotherapy, thereby reducing cumulative treatment welfare burden. In shelter settings, evidence-based protocols that prioritise treatment speed protect both individual cat welfare and population welfare by reducing quarantine pressure on limited space.